Sector valuations Laboratorios Farmaceuticos Rovi, S.A. OTC Markets
Stocks
LABFF
ES0157261019
Pharmaceuticals
|
Market Closed -
Other stock markets
|
5-day change | 1st Jan Change | ||
| 65.86 USD | -27.31% |
|
-.--% | - |
| May. 13 | Spanish stocks - Factors to watch on May 13 | RE |
| May. 09 | Laboratorios Farmaceuticos Rovi, S.A., Q1 2026 Earnings Call, May 06, 2026 |
Main competitors
| P/E (Y) | Price to Book (Y) | PEG (Y) | EV / Sales (Y) | EV / EBITDA (Y) | EV / EBIT (Y) | Dividend Yield (Y) | Capi.($) | ||
|---|---|---|---|---|---|---|---|---|---|
| 32.01x | 19.31x | 0.65x | 11.69x | 23.99x | 24.55x | 0.62% | 980B | ||
| 24.41x | 6.15x | -1.61x | 5.63x | 15.32x | 16.94x | 2.34% | 550B | ||
| 26.86x | -788.07x | 0.11x | 6.49x | 13.28x | 13.63x | 3.17% | 382B | ||
| 17.04x | 6.33x | 1x | 4.24x | 10.43x | 11.77x | 3.13% | 316B | ||
| 21.94x | 5.11x | 1x | 4.59x | 13.02x | 13.69x | 1.91% | 272B | ||
| 20.28x | 6.08x | 115.42x | 5.27x | 12.78x | 13.96x | 3.05% | 268B | ||
| 13x | 5.61x | -6.14x | 4.83x | 9.94x | 11.61x | 3.87% | 199B | ||
| 21.95x | 16.37x | 2.72x | 5.91x | 10.33x | 13.54x | 2.99% | 182B | ||
| -44.34x | 8.41x | 0.31x | 5.36x | 29.54x | 59.61x | 2.62% | 154B | ||
| 11.79x | 1.64x | 0.21x | 3.11x | 7.57x | 8.81x | 6.95% | 144B | ||
| 25.82x | 5.18x | 1.82x | 7.81x | 17.62x | 18.34x | -.--% | 115B | ||
| 10.58x | 4.68x | 0.22x | 2.93x | 7.84x | 8.52x | 4.66% | 110B | ||
| 11.03x | 1.19x | 2.19x | 2.12x | 6.85x | 7.78x | 5.74% | 102B | ||
| 12.36x | 4.46x | 1.19x | 2.69x | 7.92x | 8.94x | 3.64% | 101B | ||
| 24.33x | 5.53x | 1.38x | 8.29x | 15.68x | 16.4x | 1.81% | 77.05B | ||
| 40.17x | 1.04x | 58.68x | 2.53x | 9.3x | 25.75x | 4.14% | 48.34B | ||
| 34.42x | 4.65x | 1.79x | 7.63x | 25.45x | 26.3x | 0.56% | 47.32B | ||
| 16.08x | 1.31x | -0.1x | 1.51x | 7.17x | 11.93x | 0.58% | 42.64B | ||
| Average | 17.76x | -38.06x | 10.05x | 5.15x | 13.56x | 17.34x | 2.88% | 227.21B | |
| Weighted average by Cap. | 21.01x | -65.05x | 8.38x | 6.66x | 15.72x | 18.09x | 2.45% |
Select your edition
All financial news and data tailored to specific country editions
















